Predictors of post-ERCP complications in patients with suspected choledocholithiasis

被引:104
作者
Mehta, SN
Pavone, E
Barkun, JS
Bouchard, S
Barkun, AN
机构
[1] McGill Univ, Montreal Gen Hosp, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Montreal Gen Hosp, Div Gen Surg, Montreal, PQ H3G 1A4, Canada
[3] McGill Univ, Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
关键词
D O I
10.1055/s-2007-1001308
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Study Aims: Determinants of complications after endoscopic retrograde cholangiopancreatography (ERCP) have not yet been completely characterized, Patients and Methods: Data were collected from an endoscopic database. Univariate analysis and multivariate logistic regression analysis were used to generate the best model of independent predictors of post-ERCP pancreatitis, Results: The database included 1239 ERCP examinations carried out to investigate suspected choledocholithiasis over a five-year period. From these, 45 patients who developed post-ERCP complications were compared to a random sample of 486 patients who had undergone an uncomplicated ERCP for suspected choledocholithiasis, Univariate analysis demonstrated significant differences between the two patient groups for the following factors: age, using a cut-off point of 59 years (27% vs. 51%, P = 0.002), pancreatic channel opacification (73% vs. 58%, P = 0.05), and absence of common bile duct stones (41% vs. 24%, P = 0.03), Using multivariate logistic regression, the best model for predicting post-ERCP pancreatitis in patients undergoing sphincterotomy included age under 59 years (P = 0.04), and absence of a common bile duct stone (P = 0.004), The model yielded probabilities of developing post-sphincterotomy pancreatitis that ranged from 2.8% if no predictor was present, to 27% when both predictors were present. Among patients in whom a sphincterotomy was not performed, the only significant independent predictor found was pancreatic channel opacification (P = 0,05), Conclusion: Age under 59 years, pancreatic channel opacification, and an absence of common bile duct stones at ERCP are all independent predictors of post-ERCP pancreatitis.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 52 条
[1]   DIAGNOSIS OF CHOLEDOCHOLITHIASIS BY ENDOSCOPIC ULTRASONOGRAPHY [J].
AMOUYAL, P ;
AMOUYAL, G ;
LEVY, P ;
TUZET, S ;
PALAZZO, L ;
VILGRAIN, V ;
GAYET, B ;
BELGHITI, J ;
FEKETE, F ;
BERNADES, P .
GASTROENTEROLOGY, 1994, 106 (04) :1062-1067
[2]   THE USE OF A LONG-ACTING SOMATOSTATIN ANALOG (OCTREOTIDE) FOR PROPHYLAXIS OF ACUTE-PANCREATITIS AFTER ENDOSCOPIC SPHINCTEROTOMY [J].
ARCIDIACONO, R ;
GAMBITTA, P ;
ROSSI, A ;
GROSSO, C ;
BINI, M ;
ZANASI, G .
ENDOSCOPY, 1994, 26 (09) :715-718
[3]  
BARKIN JS, 1991, AM J GASTROENTEROL, V86, P1437
[4]   DOES THE SOMATOSTATIN ANALOG OCTREOTIDE PROTECT AGAINST ERCP INDUCED PANCREATITIS [J].
BINMOELLER, KF ;
HARRIS, AG ;
DUMAS, R ;
GRIMALDI, C ;
DELMONT, JP .
GUT, 1992, 33 (08) :1129-1133
[5]  
BOCKMAN DE, 1971, ARCH SURG-CHICAGO, V103, P321
[6]   ENDOSCOPIC PAPILLOTOMY FOR COMMON BILE-DUCT STONES - FACTORS INFLUENCING THE COMPLICATION RATE [J].
BOENDER, J ;
NIX, GAJJ ;
DERIDDER, MAJ ;
VANBLANKENSTEIN, M ;
SCHUTTE, HE ;
DEES, J ;
WILSON, JHP .
ENDOSCOPY, 1994, 26 (02) :209-216
[7]  
CATTAU E, 1988, GASTROINTEST ENDOSC, V34, P185
[8]   Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography [J].
Cavallini, G ;
Tittobello, A ;
Frulloni, L ;
Masci, E ;
Mariani, A ;
DiFrancesco, V ;
Angelini, GP ;
Casarini, MB ;
Bedogni, G ;
Conigliaro, R ;
Bonardi, L ;
Khajekini, MTA ;
Cipolletta, L ;
Bianco, MA ;
Costamagna, G ;
Perri, V ;
Dobrilla, G ;
DePretis, G ;
Familiari, L ;
Giacobbe, G ;
Fratton, A ;
Carone, N ;
Loriga, P ;
Muscas, A ;
Mazzeo, F ;
Gaeta, L ;
Miglioli, M ;
Pezzilli, R ;
Morelli, A ;
Santucci, L ;
Naccarato, R ;
DelFavero, G ;
Orlandi, F ;
Macarri, GP ;
Russo, A ;
Virgilio, C ;
Uomo, G ;
Manes, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13) :919-923
[9]  
CHEN YK, 1994, AM J GASTROENTEROL, V89, P327
[10]  
CLASSEN M, 1986, CLIN GASTROENTEROL, V15, P457